Trial ID: | L0134 |
Source ID: | NCT01991574
|
Associated Drug: |
Calcium Acetate
|
Title: |
Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Healthy|Chronic Kidney Diseases
|
Interventions: |
DRUG: Calcium acetate|DIETARY_SUPPLEMENT: Iron Hydroxide Adipate|DRUG: Placebo
|
Outcome Measures: |
Primary: urinary phosphate, To determine if the ingestion of ferric hydroxide adipate with food induces a reduction in urinary phosphate concentration, compared with the administration of placebo plus the same food on a different occasion., 9 hours | Secondary: iron absorption, iron absorption from the ferric hydroxide adipate treatment will be determined by labelling this preparation with 58Fe and measuring day 14 erythrocyte 57Fe:58Fe., 14 days
|
Sponsor/Collaborators: |
Sponsor: Medical Research Council
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
EARLY_PHASE1
|
Enrollment: |
30
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
|
Start Date: |
2009-04
|
Completion Date: |
2009-10
|
Results First Posted: |
|
Last Update Posted: |
2017-02-06
|
Locations: |
MRC Human Nutrition Research, Cambridge, Cambridgeshire, CB1 9NL, United Kingdom
|
URL: |
https://clinicaltrials.gov/show/NCT01991574
|